Buzz Stocks: Cisco Systems, Inc., Pep Boys-Manny Moe and Jack, and Neurometrix Inc

Today's stocks to watch include Cisco Systems, Inc. (CSCO), Pep Boys-Manny Moe and Jack (PBY), and Neurometrix Inc (NURO)

by Alex Eppstein

Published on Dec 29, 2015 at 9:29 AM

U.S. markets are set to open higher as oil prices recover. Among the equities in focus are tech titan Cisco Systems, Inc. (NASDAQ:CSCO), auto parts dealer Pep Boys-Manny Moe and Jack (NYSE:PBY), and medical device maker Neurometrix Inc (NASDAQ:NURO).

A U.S. appeals court ruled that CSCO did not infringe on a Commil USA wifi technology patent, reversing a prior judgment worth $64 million. The good news has Cisco Systems, Inc. up 0.4% pre-market, as it tries to fight back from a 1.8% year-to-date deficit, settling Monday night at $27.31. Option traders have been more bearish than usual toward the stock. CSCO's 10-day put/call volume ratio of 0.64 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) outstrips all but 15% of comparable readings taken during the past year.

PBY is moving to terminate a buyout agreement with Bridgestone after its board determined Carl Icahn's latest offer -- valuing Pep Boys at $1 billion, or $18.50 per share -- is superior. The move has sent the shares 7% higher ahead of the open. This is more of the same for a stock that's soared over 43% to trade at $17.41 since its close on Oct. 23, just ahead of Bridgestone's initial takeover bid. Amid this rapid run-up, traders have been buying to open puts over calls at an accelerated clip, per Pep Boys-Manny Moe and Jack's 50-day put/call volume ratio of 0.39 -- registering in the 86th percentile of its annual range.

NURO is set to surge 26.5% at the open after the firm said it's launching a nerve conduction test in Mexico, which will be used to evaluate systemic neuropathies, common in patients with type 2 diabetes. The expected gap higher is a welcome change of pace for shareholders, who have watched the stock lose 70% of its value in 2015 to trade at $2.30 -- and hit a record low of $2.18 earlier this month. Despite this poor technical track record, both of the analysts following Neurometrix Inc rate it a "strong buy."

Follow @Schaeffers

A Schaeffer's exclusive

TOP STOCK PICKS 2020

Access your FREE insider report before it's too late!

Browse By Topic

View All Articles By Date

Partnercenter

^NEW!Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers. Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.